PROM1 and glioblastoma: Analysis of GBM tumor tissues from 95 cases revealed that CD133 expression correlates with GBM patient survival (Brescia et al., 2013) and is essential for maintaining glioblastoma stem cell (GSC) stemness (Zeppernick et al., 2008).